As of 2025-07-13, the Relative Valuation of Neogenomics Inc (NEO) is (15.18) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.26 USD, the upside of Neogenomics Inc based on Relative Valuation is -309.1%.
The range of the Relative Valuation is (14.49) - (15.63) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 24.0x - 30.0x | 27.6x |
| Forward P/E multiples | 21.4x - 25.9x | 22.8x |
| Fair Price | (14.49) - (15.63) | (15.18) |
| Upside | -299.6% - -315.3% | -309.1% |
| Date | P/E |
| 2025-07-11 | -12.04 |
| 2025-07-10 | -12.42 |
| 2025-07-09 | -12.49 |
| 2025-07-08 | -12.36 |
| 2025-07-07 | -12.12 |
| 2025-07-03 | -12.52 |
| 2025-07-02 | -12.27 |
| 2025-07-01 | -12.29 |
| 2025-06-30 | -12.12 |
| 2025-06-27 | -11.91 |
| 2025-06-26 | -11.88 |
| 2025-06-25 | -11.91 |
| 2025-06-24 | -11.99 |
| 2025-06-23 | -11.63 |
| 2025-06-20 | -11.61 |
| 2025-06-18 | -11.53 |
| 2025-06-17 | -11.59 |
| 2025-06-16 | -12.29 |
| 2025-06-13 | -11.73 |
| 2025-06-12 | -12.26 |
| 2025-06-11 | -12.99 |
| 2025-06-10 | -13.00 |
| 2025-06-09 | -12.54 |
| 2025-06-06 | -12.31 |
| 2025-06-05 | -11.83 |
| 2025-06-04 | -12.24 |
| 2025-06-03 | -12.41 |
| 2025-06-02 | -11.89 |
| 2025-05-30 | -12.07 |
| 2025-05-29 | -12.22 |
| 2025-05-28 | -12.31 |
| 2025-05-27 | -12.44 |
| 2025-05-23 | -12.29 |
| 2025-05-22 | -12.07 |
| 2025-05-21 | -12.27 |
| 2025-05-20 | -13.25 |
| 2025-05-19 | -13.37 |
| 2025-05-16 | -13.45 |
| 2025-05-15 | -13.00 |
| 2025-05-14 | -13.20 |
| 2025-05-13 | -13.87 |
| 2025-05-12 | -14.11 |
| 2025-05-09 | -13.35 |
| 2025-05-08 | -13.48 |
| 2025-05-07 | -13.27 |
| 2025-05-06 | -12.75 |
| 2025-05-05 | -13.00 |
| 2025-05-02 | -12.77 |
| 2025-05-01 | -12.04 |
| 2025-04-30 | -10.61 |